Literature DB >> 21795803

Crystallization and preliminary X-ray analysis of 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (IspE) from Mycobacterium tuberculosis.

Shan Shan1, Xuehui Chen.   

Abstract

The 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (IspE) from Mycobacterium tuberculosis, an enzyme from the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway, is crucial and essential for the survival of this pathogenic bacterium. IspE catalyzes the conversion of 4-diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) to 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-phosphate (CDP-ME2P) in an ATP-dependent manner. Solving the crystal structure of M. tuberculosis IspE will shed light on its structural details and mechanism of action and may provide the basis for the future design of drugs for the treatment of multidrug-resistant and extremely drug-resistant M. tuberculosis strains. Recombinant M. tuberculosis IspE was crystallized at 291 K using NaCl or Li2SO4 as a precipitant. A 2.1 Å resolution native data set was collected from a single flash-cooled crystal (100 K) belonging to space group P2(1)2(1)2(1), with unit-cell parameters a=52.5, b=72.3, c=107.3 Å. One molecule was assumed per asymmetric unit, which gives a Matthews coefficient of 3.4 Å3 Da(-1) with 63% solvent content.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795803      PMCID: PMC3144805          DOI: 10.1107/S1744309111019567

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  18 in total

1.  Sequence and structure classification of kinases.

Authors:  Sara Cheek; Hong Zhang; Nick V Grishin
Journal:  J Mol Biol       Date:  2002-07-19       Impact factor: 5.469

2.  Biosynthesis of isoprenoids: crystal structure of 4-diphosphocytidyl-2C-methyl-D-erythritol kinase.

Authors:  Linda Miallau; Magnus S Alphey; Lauris E Kemp; Gordon A Leonard; Sean M McSweeney; Stefan Hecht; Adelbert Bacher; Wolfgang Eisenreich; Felix Rohdich; William N Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

Review 3.  Biosynthesis of isoprenoids via the non-mevalonate pathway.

Authors:  W Eisenreich; A Bacher; D Arigoni; F Rohdich
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

4.  Expression and characterization of soluble 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase from bacterial pathogens.

Authors:  Hyungjin Eoh; Prabagaran Narayanasamy; Amanda C Brown; Tanya Parish; Patrick J Brennan; Dean C Crick
Journal:  Chem Biol       Date:  2009-12-24

Review 5.  Structure-based drug design targeting biosynthesis of isoprenoids: a crystallographic state of the art of the involved enzymes.

Authors:  J de Ruyck; J Wouters
Journal:  Curr Protein Pept Sci       Date:  2008-04       Impact factor: 3.272

Review 6.  The methylerythritol phosphate pathway and its significance as a novel drug target.

Authors:  C A Testa; M J Brown
Journal:  Curr Pharm Biotechnol       Date:  2003-08       Impact factor: 2.837

Review 7.  The cell-wall core of Mycobacterium tuberculosis in the context of drug discovery.

Authors:  Patrick J Brennan; Dean C Crick
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

8.  Characterization of Aquifex aeolicus 4-diphosphocytidyl-2C-methyl-d-erythritol kinase - ligand recognition in a template for antimicrobial drug discovery.

Authors:  Tanja Sgraja; Magnus S Alphey; Stephanos Ghilagaber; Rudi Marquez; Murray N Robertson; Jennifer L Hemmings; Susan Lauw; Felix Rohdich; Adelbert Bacher; Wolfgang Eisenreich; Victoria Illarionova; William N Hunter
Journal:  FEBS J       Date:  2008-04-16       Impact factor: 5.542

9.  Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis.

Authors:  Samiul Hasan; Sabine Daugelat; P S Srinivasa Rao; Mark Schreiber
Journal:  PLoS Comput Biol       Date:  2006-06-09       Impact factor: 4.475

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.